Relevant Transactions – Cariola Díez Pérez-Cotapos

We advised Quillayes, a Chilean dairy company, in a merger agreement with Surlat, a dairy company controlled by the Swiss company Emmi AG. This merger contemplates the creation of a joint holding entity under the name of Quillayes Surlat, which shall control the operating entities through which both Quillayes and Surlat carry out currently their business.

January 2020

We advised EPM in the sale of the local company owning Parque Eólico Los Cururos to an affiliate of AES Gener for a total amount of USD 138 million. We advised EPM in the process of decision making for the sale, in the due diligence, and subsequently in the negotiation and execution of the share purchase agreement.

November 2019

We advised Levi Strauss and Co. on the purchase of assets for the acquisition of the business and commercialization of its Levi's and Dockers products in Chile.

November 2019

We advised Ripley in the sale of Mall del Centro Concepción to Inmobiliaria Mall Viña del Mar.

August 2019

We advised Joyvio Group Co., Ltd. (a subsidiary of Legend Holdings) in the purchase promise agreement to acquire the listed salmon producer Australis Seafoods S.A. (“Australis”), in a deal worth approx. US$920 million.

July 2019

We represented Carlyle Group in the acquisition of Coney Park in Peru and its subsidiaries in Chile and Colombia.

July 2019

We advised the Canadian company ATCO in the acquisition of 40% of the company Neltume Ports S.A., property of Ultramar, in US$ 340 million approx.

September 2018

We advised Loomis Holder Spain S.L.U. and its Chilean subsidiaries in the acquisition of 100% of the shares of the Chilean company Compañía Chilena de Valores S.A., which conducts domestic cash handling services in Valparaíso, Chile.

June 2018

We advised AccorHotels, a French group with 335 hotels operating and 166 under development in Latin America, in the agreement to acquire the Chilean group Atton Hoteles.

May 2018

We advised Banmédica in the sale of I-Med S.A., a health technology company in which Banmédica had an indirect participation through its affiliate Saden S.A., to Accel-KKr for US$ 119 million.

January 2018

Menu